Suberoylanilide hydroxamic acid partly reverses resistance to paclitaxel in human ovarian cancer cell lines
- 1 December 2010
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 119 (3), 557-563
- https://doi.org/10.1016/j.ygyno.2010.07.036
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Epidemiology of Ovarian CancerPublished by Springer Nature ,2009
- Histone deacetylase inhibitors in cancer therapyCurrent Opinion in Oncology, 2008
- Histone DeacetylationDrugs in R&D, 2008
- Paclitaxel And Docetaxel Resistance: Molecular Mechanisms and Development of New Generation TaxanesChemMedChem, 2007
- Discovery and development of SAHA as an anticancer agentOncogene, 2007
- Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drugNature Biotechnology, 2007
- Acetylation and deacetylation of non-histone proteinsGene, 2005
- Mechanisms of Taxol resistance related to microtubulesOncogene, 2003
- Strategies for reversing drug resistanceOncogene, 2003
- Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic ManipulationCurrent Cancer Drug Targets, 2003